This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Medtronic Ireland Manufacturing Unlimited Company. Active years: 2023-2025.
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Paul Sobotka in Immune System Neuromodulation
Introduction
Paul Sobotka is an accomplished inventor based in West St. Paul, MN (US). He has made significant contributions to the field of medical technology, particularly in the area of immune system neuromodulation. With a total of 2 patents, Sobotka's work focuses on advancing treatment methods for patients with immune system conditions.
Latest Patents
Sobotka's latest patents include innovative catheter-based devices and associated methods for immune system neuromodulation. These patents disclose methods for treating human patients diagnosed with immune system conditions. One key aspect of this technology involves intravascularly positioning a neuromodulation catheter within a blood vessel near neural fibers that innervate an immune system organ. The method aims to reduce sympathetic neural activity by delivering energy to these neural fibers via the catheter. This reduction in sympathetic neural activity is designed to improve measurable physiological parameters related to the patient's immune system condition.
Career Highlights
Paul Sobotka is currently associated with Medtronic Ireland Manufacturing Unlimited Company, where he continues to develop and refine his innovative medical technologies. His work has the potential to significantly impact the treatment of various immune system disorders.
Collaborations
Sobotka collaborates with Neil Chand Barman, contributing to the advancement of their shared goals in medical innovation.
Conclusion
Paul Sobotka's contributions to immune system neuromodulation through his patents and work at Medtronic highlight his commitment to improving patient care. His innovative approaches are paving the way for new treatment options in the medical field.